EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A clinical study of the local injection of a freshly manufactured 35 kDa hyaluronan fragment for treating chronic wounds

Dylan Treger, Lujia Zhang, Xiaoxiao Jia, Jessica H Hui, Munkh-Amgalan Gantumur, Mizhou Hui, Li Liu

International Wound Journal · 2024

DOI: 10.1111/iwj.14906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Wound Journal, 2024. Verfasst von Dylan Treger und 6 weiteren Autor:innen. Beteiligte Einrichtung: Miller School of Medicine, University of Miami, Miami, Florida, USA. Hauptthemen laut MEDLINE: Hyaluronic Acid, Wound Healing, Hyaluronoglucosaminidase. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study manufactured a 35 kDa hyaluronan fragment (HA35) by enzymatically degrading high‐molecular‐weight HA using hyaluronidase PH20 derived from bovine testis. The research then examined the therapeutic efficacy of locally administered, tissue‐permeable HA35 in alleviating chronic wounds and their associated neuropathic pain. For 20 patients with nonhealing wounds and associated pain lasting over three months, 100 mg of HA35 was injected daily into the healthy skin surrounding the chronic wound for 10 days. Self‐assessments before and after treatment indicated that HA35 significantly enhanced wound healing. This was evidenced by the formation of fresh granulation tissue on the wounds ( p < 0.0001); reduced darkness, redness, dryness, and damage in the skin surrounding the wounds ( p < 0.0001), and a decrease in wound size ( p < 0.001). Remarkably, HA35 injections alleviated pain associated with chronic wounds within 24 hours ( p < 0.0001). It can be concluded that the low‐molecular‐weight hyaluronan fragment HA35 potentially enhances the immune response and angiogenesis during wound healing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidWound HealingHyaluronoglucosaminidaseMaleHumansMiddle AgedChronic DiseaseAgedFemaleAdultTreatment OutcomeWounds and InjuriesAnimalsMolecular WeightAged, 80 and over

Stichwörter der Autor:innen

35 kDa hyaluronan fragment HA35chronic woundhyaluronantissue permeabilitywound healing

Substanzen

Hyaluronic AcidHyaluronoglucosaminidase

Autor:innen und Institutionen

  • Miller School of Medicine, University of Miami, Miami, Florida, USA.
  • Peripheral Vascular Department, Far East Hospital, Harbin, China.
  • Qingdao Hui Nuo De Biotechnology Co. Ltd., Hai Shi Hai Nuo Group, Qingdao, China.
  • Nakhia Impex Pharmaceutical Co. Ltd., Ulaanbaatar, Mongolia.

Zitieren

APA

Treger, D., Zhang, L., Jia, X., Hui, J. H., Gantumur, M. A., Hui, M., & Liu, L. (2024). A clinical study of the local injection of a freshly manufactured 35 kDa hyaluronan fragment for treating chronic wounds. International Wound Journal. https://doi.org/10.1111/iwj.14906

Vancouver

Treger D, Zhang L, Jia X, Hui JH, Gantumur MA, Hui M, et al. A clinical study of the local injection of a freshly manufactured 35 kDa hyaluronan fragment for treating chronic wounds. International Wound Journal. 2024. doi:10.1111/iwj.14906

BibTeX
@article{Treger2024,
  author = {Treger, Dylan and Zhang, Lujia and Jia, Xiaoxiao and Hui, Jessica H and Gantumur, Munkh-Amgalan and Hui, Mizhou and Liu, Li},
  title = {A clinical study of the local injection of a freshly manufactured 35 kDa hyaluronan fragment for treating chronic wounds},
  journal = {International Wound Journal},
  year = {2024},
  doi = {10.1111/iwj.14906}
}
Kostenlos starten →